UPDATE 1-U.S. FDA advisory panel backs Takeda bowel disease drug

An advisory panel of medical experts on Monday voted to recommend that U.S. health regulators approve an experimental drug for ulcerative colitis and Crohn's disease developed by Takeda Pharmaceutical Co.


More...